Switch to: References

Add citations

You must login to add citations.
  1. Die Rechte zukünftiger Kinder im Kontext pränataler Diagnostik.Dagmar Schmitz & Marcus Düwell - 2021 - Ethik in der Medizin 34 (1):49-63.
    Das Gendiagnostikgesetz verbietet seit 2010 die pränatale Diagnostik spätmanifestierender Erkrankungen GenDG). In seiner Begründung bezog sich der Gesetzgeber in Analogie zu internationalen Empfehlungen für den pädiatrischen Bereich vor allem auf das Recht des heranwachsenden Kindes bzw. des späteren Erwachsenen auf Nichtwissen. Mit diesem gesetzlichen Verbot hat Deutschland einen viel diskutierten Sonderweg in der Regulierung genetischer Pränataldiagnostik eingeschlagen. Seither jedoch hat sich nicht nur die Perspektive auf prädiktive Testungen im Kindesalter verändert. In zunehmendem Maße generieren auf das gesamte Genom abzielende Diagnostikangebote (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Ethics experts and fetal patients: a proposal for modesty.Angus Clarke & Dagmar Schmitz - 2021 - BMC Medical Ethics 22 (1):1-7.
    BackgroundEthics consultation is recognized as an opportunity to share responsibility for difficult decisions in prenatal medicine, where moral intuitions are often unable to lead to a settled decision. It remains unclear, however, if the general standards of ethics consultation are applicable to the very particular setting of pregnancy.Main textWe sought to analyze the special nature of disagreements, conflicts and value uncertainties in prenatal medicine as well as the ways in which an ethics consultation service (ECS) could possibly respond to them (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Why public funding for non-invasive prenatal testing (NIPT) might still be wrong: a response to Bunnik and colleagues.Dagmar Schmitz - 2020 - Journal of Medical Ethics 46 (11):781-782.
    Bunnik and colleagues argued that financial barriers do not promote informed decision-making prior to prenatal screening and raise justice concerns. If public funding is provided, however, it would seem to be important to clarify its intentions and avoid any unwarranted appearance of a medical utility of the testing.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • A Capabilities Approach to Prenatal Screening for Fetal Abnormalities.Greg Stapleton, Wybo Dondorp, Peter Schröder-Bäck & Guido de Wert - 2019 - Health Care Analysis 27 (4):309-321.
    International guidelines recommend that prenatal screening for fetal abnormalities should only be offered within a non-directive framework aimed at enabling women in making meaningful reproductive choices. Whilst this position is widely endorsed, developments in cell-free fetal DNA based Non-Invasive Prenatal Testing are now raising questions about its continued suitability for guiding screening policy and practice. This issue is most apparent within debates on the scope of the screening offer. Implied by the aim of enabling meaningful reproductive choices is the idea (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Non-invasive Prenatal Testing for Fetal Whole Genome Sequencing: An Interpretive Critical Review of the Ethical, Legal, Social, and Policy Implications.Hazar Haidar & Renata Iskander - 2022 - Canadian Journal of Bioethics / Revue canadienne de bioéthique 5 (1).
    Introduction: Non-invasive prenatal testing allows for genetic testing of a fetus through the analysis of cell-free DNA from the mother’s plasma. NIPT is easy and safe for the fetus, since it only requires a blood draw from the mother and therefore holds no risk of miscarriage. It is considered superior to other prenatal screening tests and can also be performed earlier in the pregnancy. NIPT has the future potential for fetal whole genome sequencing for an expanded range of conditions, such (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • A Capabilities Approach to Prenatal Screening for Fetal Abnormalities.Guido Wert, Peter Schröder-Bäck, Wybo Dondorp & Greg Stapleton - 2019 - Health Care Analysis 27 (4):309-321.
    International guidelines recommend that prenatal screening for fetal abnormalities should only be offered within a non-directive framework aimed at enabling women in making meaningful reproductive choices. Whilst this position is widely endorsed, developments in cell-free fetal DNA based Non-Invasive Prenatal Testing are now raising questions about its continued suitability for guiding screening policy and practice. This issue is most apparent within debates on the scope of the screening offer. Implied by the aim of enabling meaningful reproductive choices is the idea (...)
    Download  
     
    Export citation  
     
    Bookmark